Several companies and technology groups have begun developing smartphone applications or systems for individuals to upload details of their COVID-19 tests and vaccinations, creating digital credentials that could be displayed to enter concert venues. stadiums, cinemas, offices or even countries. .
The Common Trust Network, an initiative of the Geneva nonprofit, The Commons Project and the World Economic Forum, has collaborated with several airlines, including Cathay Pacific, JetBlue, Lufthansa, Swiss Airlines, United Airlines and Virgin Atlantic, as well as hundreds of health systems across the United States and the Aruba government.
The CommonPass application created by the group allows users to upload medical data, such as the result of the COVID-19 test or, finally, a proof of vaccination by a hospital or a medical professional, generating a health certificate or pass in the form a QR code that can be presented to the authorities without disclosing sensitive information. For travel, the app lists the requirements for health permits at points of departure and arrival based on your itinerary.
“You can be tested every time you cross a border. You can’t be vaccinated every time you cross a border,” Thomas Crampton, chief marketing and communications officer for The Commons Project, told CNN Business. He emphasized the need for a simple and easy-to-transfer set of accreditations or a “digital yellow card”, referring to the paper document generally issued as proof of vaccination.
RELATED: US carefully analyzes variant of coronavirus that has triggered alarms in the UK, says Fauci
Large technology companies are also taking action. IBM has developed its own application, called the Digital Health Pass, that allows companies and locations to customize the indicators they would need for entry, including coronavirus testing, temperature checks and vaccination records. The credentials corresponding to these indicators are then stored in a mobile wallet.
In an effort to address a challenge to return to normalcy after vaccines are widely distributed, developers may now need to address other challenges, from privacy issues to the various efficacies of different vaccines. vaccines. But the most pressing challenge could simply be to avoid the disjoint implementation and mixed success of the previous technology attempt to address the public health crisis: contact tracking applications.
At the beginning of the pandemic, Apple and Google put aside their smartphone rivalry to jointly develop a Bluetooth-based system to let users know if they had been exposed to COVID-19. Many countries and state governments around the world have developed and used their own applications.
“I think if the exposure notification faced some challenges it was more of the fractional implementation options, the lack of federal leadership … where each state had to go it alone and so each state had to give independently, ”said Jenny Wanger, who leads the exposure notification initiatives for the Linux Foundation Public Health, a technology-focused organization that helps public health authorities around the world fight COVID-19.
To encourage better coordination this time around, the Linux Foundation has partnered with the COVID-19 Credentials Initiative, a team of more than 300 people representing dozens of organizations on five continents and also working with IBM and CommonPass to helps develop a set of universal standards for vaccine accreditation applications.
“If we are successful, you should be able to say: I have a vaccine certificate on the phone that I received when I was vaccinated in a country, with a whole set of my own types of health management practices … on who used to board a plane to a completely different country and then I presented in that new country a vaccination accreditation to be able to go to that concert that took place indoors for which attendance was limited to those who demonstrated that they had the vaccine, “said Brian Behlendorf, executive director of the Linux Foundation.
“It should be interoperable in the same way that email is interoperable, in the same way that the web is interoperable,” he said. “Right now, we are in a situation where there are some moving parts that bring us closer to that, but I think there is a sincere commitment from everyone in the industry.”
Part of ensuring the widespread use of vaccine passports is to represent the large subset of the global population that does not yet use or have access to smartphones. Several COVID-19 Accreditation Initiative companies are also developing a smart card that creates a middle ground between traditional paper vaccine certificates and an online version that is easier to store and reproduce.
“It simply came to our notice then [about] how those digital credentials can be stored, presented, not only via smartphones, but also in other ways for those people who do not have stable internet access and also who do not have smartphones. ” said Lucy Yang, co-leader of the COVID-19 Accreditation Initiative. “We look at it and there are companies that are doing some really promising work.
Once they build a vaccine passport, companies will need to make sure people feel comfortable using it. This means addressing concerns about the treatment of private medical information.
CommonPass, IBM and the Linux Foundation have all emphasized privacy as a core element of their initiatives. IBM says it allows users to control and consent to the use of their health data and allows them to choose the level of detail they want to provide to the authorities.
“Trust and transparency remain paramount when developing a platform such as a digital health passport or any solution that manages sensitive personal information,” the company said in a blog post. “Putting confidentiality first is an important priority for data management and analysis in response to these complex periods.”
With vaccines manufactured by several companies in several countries at different stages of development, there are a lot of variables that passport manufacturers will have to consider.
“An entry point – whether it’s a border or a place – will want to know, did you get the Pfizer vaccine, did you get the Russian vaccine, did you get the Chinese vaccine, so that they can make a decision? accordingly, “said Crampton. The variation can be wide: the vaccine developed by Chinese pharmaceutical giant Sinopharm, for example, has an 86% efficacy against COVID-19, while the vaccines produced by Pfizer and Moderna each have an efficacy of about 95%.
It is also unclear how effective vaccines are at stopping the transmission of the virus, says Dr. Julie Parsonnet, a specialist in infectious diseases at Stanford University. So while a vaccine passport application will show that you received the shot, it may not be a guarantee that you are safely participating in an event or boarding a flight.
“We still don’t know if vaccinated people can transmit the infection or not,” she told CNN Business. “Until this is clarified, we will not know if the ‘passports’ will be effective.”
However, Behlendorf anticipates that the launch and adoption of vaccine passports will happen fairly quickly once everything is in place and expects a variety of applications that can work with each other to be “widely available” in the first half of the year. of the year 2021.
“Be sure, the nerds are on him,” he said.
The-CNN-Wire ™ and © 2020 Cable News Network, Inc., a WarnerMedia company. All rights reserved.